Skip to main content

Day: April 5, 2024

WENDEL: Wendel successfully completes the sale of 9% of Bureau Veritas’ share capital

Written by Customer Service on . Posted in Mergers And Acquisitions.

 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. THESE MATERIALS ARE NOT AN OFFER FOR SALE OF SECURITIES IN THE UNITED STATES. SECURITIES MAY NOT BE SOLD IN THE UNITED STATES ABSENT REGISTRATION WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR AN EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED.  THE ISSUER OF THE SECURITIES DOES NOT INTEND TO REGISTER ANY PART OF THE OFFERING IN THE UNITED STATES OR TO CONDUCT A PUBLIC OFFERING OF THE SECURITIES IN THE UNITED STATES. THIS PRESS RELEASE IS FOR INFORMATION PURPOSE ONLY AND DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY SECURITIES AND THE...

Continue reading

Lerøy Seafood Group ASA: Trading update Q1 2024

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

HARVEST VOLUMES OF SALMON AND TROUT Total harvest volume of salmon and trout for Q1 2024 was 26,400 GWT, excluding volumes from Scottish Seafarms. Harvest volumes per region/company (in 1,000 GWT): Lerøy Aurora: 6.0 Lerøy Midt: 13.7 Lerøy Sjøtroll: 6.7 (of which 3.3 was trout) CATCH VOLUMES OF WILDFISH Total wild catch volumes (Lerøy Havfisk) was 24,100 tonnes for Q1 2024 of which 6,700 tonnes of cod. The complete Q1 2024 report will be released on 15 May 2024 at 06:30 CET. Queries may be addressed to the company’s CFO Sjur S. Malm. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.

Continue reading

Digicann Ventures Grants Restricted Share Units

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) — Digicann Ventures Ltd. (“Digicann” or the “Company”) (CSE: DCNN) (OTCPK: AGFAD), a company focused on opportunities within and outside of the cannabis industry, announces that it has granted 1,696,815 restricted share units (the “RSUs“) to certain directors and officers of the Company. The RSUs are granted pursuant to the terms of the RSU Plan approved by the shareholders of the Company and are subject to the policies of the Canadian Securities Exchange. About Digicann Ventures Inc. Digicann Ventures Inc. is a company focused on opportunities within and outside of the cannabis industry. For more information about Digicann Ventures Inc. please visit www.digicann.io and its profile page on SEDAR at www.sedarplus.ca. ON BEHALF OF THE BOARD OF DIRECTORS Nick...

Continue reading

Sirona Biochem Announces Close of Private Placement

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) — Vancouver, British Columbia – April 4, 2024 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt: ZSB) (“Sirona”) has closed its private placement (Private Placement”) for gross proceeds of $132,500 CAD. The Private Placement consists of 1,325,000 units, (the “Units”) at a price of $0.10 per Unit. Each Unit consists of one common share and one transferable share purchase warrant, each whole warrant exercisable into one additional common share of the Company for a period of 2 years from the date of issue at a price of $0.15 per Share in year one and $0.25 per Share in year two. All securities issued under the Private Placement are subject to statutory hold periods expiring on August 4, 2024. Proceeds will be used for general working capital purposes. No insiders participated...

Continue reading

Contineum Therapeutics Announces Pricing of Initial Public Offering

Written by Customer Service on . Posted in Public Companies.

SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) — Contineum Therapeutics, Inc. (Contineum), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of neuroscience, inflammation and immunology indications with high unmet need, today announced the pricing of its initial public offering of 6,875,000 shares of its Class A common stock at a price to the public of $16.00 per share. All of the shares are being offered by Contineum. The gross proceeds to Contineum from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Contineum, are expected to be $110.0 million. The shares are expected to begin trading on The Nasdaq Global...

Continue reading

DMG Blockchain Solutions Announces March Mining Results

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG” or the “Company”), a vertically integrated blockchain and data center technology company, announces March 2024 preliminary mining results: DMG mined 49.8 bitcoin with 1.0 EH/s realized hashrate. DMG’s bitcoin balance as of March 31, 2024 was 446 bitcoin. DMG Management at the DigitalABC’s First Annual Blockchain Law, Regulation and Policy Conference on April 8 in Ottawa, Canada DMG management will appear on panel discussions for the first annual Blockchain Law, Regulation and Policy Conference & Reception held on April 8, 2024 at the Sheraton Ottawa, organized by the Digital Asset Business Council (DigitalABC) as well as the Canadian Blockchain Consortium. Key topics to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.